Crossmark

GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma

Published Online: 2016-05-09

Published Print: 2016-11-24

Authors

Yuan, S

Yu, Z

Liu, Q

Zhang, M

Xiang, Y

Wu, N

Wu, L

Hu, Z

Xu, B

Cai, T

Ma, X

Zhang, Y

Liao, C

Wang, L

Yang, P

Bai, L

Li, Y
License Information

Text and Data Mining valid from 2016-05-09

Version of Record valid from 2016-05-09
More Information

Article History

Received: 27 September 2015

Revised: 19 March 2016

Accepted: 25 March 2016

First Online: 9 May 2016

Competing interests

: The authors declare no conflict of interest.

Document is current